Concepedia
Statistics
Publications
205
Citations
22.8K
H-Index
63
Active since
1975
Affiliations
Sarah Cannon(Current)
Tennessee Oncology
Memorial Sloan Kettering Cancer Center
The University of Texas MD Anderson Cancer Center
Dana-Farber Cancer Institute
Melissa L. Johnson is an author at Sarah Cannon specializing in oncology, medicine, and pharmacology.
Publications per year
1975–2026
First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer
Leora Horn, Aaron S. Mansfield, Aleksandra Szczęsna et al. · New England Journal of Medicine · 2018 · 3.5K citations · Full text
Medicine, Oncology, Pharmacology +17
PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell Carcinoma
Michael R. Migden, Danny Rischin, Chrysalyne D. Schmults et al. · New England Journal of Medicine · 2018 · 1.4K citations · Full text
Medicine, Oncology, Pharmacotherapy +17
The KRASG12C Inhibitor MRTX849 Provides Insight toward Therapeutic Susceptibility of KRAS-Mutant Cancers in Mouse Models and Patients
Jill Hallin, Lars D. Engstrom, Lauren Hargis et al. · Cancer Discovery · 2019 · 1.3K citations · Full text
Adagrasib in Non–Small-Cell Lung Cancer Harboring a <i> KRAS <sup>G12C</sup> </i> Mutation
Pasi A. Jänne, Gregory J. Riely, Shirish M. Gadgeel et al. · New England Journal of Medicine · 2022 · 984 citations · Full text
Medicine, Oncology, Pharmacology +15
Efficacy of Selpercatinib in <i>RET</i> Fusion–Positive Non–Small-Cell Lung Cancer
Alexander Drilon, Geoffrey R. Oxnard, Daniel Shao-Weng Tan et al. · New England Journal of Medicine · 2020 · 836 citations · Full text
Medicine, Oncology, Pharmacotherapy +13
1–5 of 205